Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS Mixed Micelles

[Image: see text] Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-small-cell lung, breast, and ovarian cancers. The major deficiencies of current gemcitabine therapy, however, are its rapid metabolic inactivation and narrow therapeutic window. Herein, we employe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Yingzhe, Fan, Wei, Dai, Xin, Katragadda, Usha, Mckinley, DeAngelo, Teng, Quincy, Tan, Chalet
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2014
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3993932/
https://ncbi.nlm.nih.gov/pubmed/24579673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp4005904
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars